Literature DB >> 2182156

Thyroxine replacement treatment and osteoporosis.

J A Franklyn1, M C Sheppard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182156      PMCID: PMC1662459          DOI: 10.1136/bmj.300.6726.693

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

1.  Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women.

Authors:  T L Paul; J Kerrigan; A M Kelly; L E Braverman; D T Baran
Journal:  JAMA       Date:  1988-06-03       Impact factor: 56.272

2.  Thyroxine replacement treatment: clinical judgment or biochemical control?

Authors:  A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

Review 3.  Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery.

Authors:  C Becker
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

4.  Grades of subclinical hypothyroidism in asymptomatic autoimmune thyroiditis revealed by the thyrotropin-releasing hormone test.

Authors:  P A Bastenie; M Bonnyns; L Vanhaelst
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

5.  Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.

Authors:  C J Pearce; R L Himsworth
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

6.  The spectrum of thyroid disease in a community: the Whickham survey.

Authors:  W M Tunbridge; D C Evered; R Hall; D Appleton; M Brewis; F Clark; J G Evans; E Young; T Bird; P A Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

7.  Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure.

Authors:  W M Tunbridge; D C Evered; R Hall; D Appleton; M Brewis; F Clark; J G Evans; E Young; T Bird; P A Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

8.  Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".

Authors:  P E Jennings; B P O'Malley; K E Griffin; B Northover; F D Rosenthal
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

9.  Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine.

Authors:  D S Ross; R M Neer; E C Ridgway; G H Daniels
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

10.  Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.

Authors:  G J Beckett; H A Kellett; S M Gow; A J Hussey; J D Hayes; A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17
View more
  6 in total

Review 1.  Endocrinology.

Authors:  M A Baxter; M C Sheppard
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

2.  Thyroxine replacement treatment and osteoporosis.

Authors: 
Journal:  BMJ       Date:  1990-04-21

Review 3.  Adverse effects of thyroid hormones.

Authors:  J B Williams
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

4.  Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.

Authors:  P De Whalley
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

5.  Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.

Authors:  J V Parle; J A Franklyn; K W Cross; S R Jones; M C Sheppard
Journal:  Br J Gen Pract       Date:  1993-03       Impact factor: 5.386

6.  Are patients with primary hypothyroidism in India receiving appropriate thyroxine replacement? An observational study.

Authors:  Ambrish Mithal; Mala Dharmalingam; Neeraj Tewari
Journal:  Indian J Endocrinol Metab       Date:  2014-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.